Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit)

v3.23.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss)
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance as of the end of period $ 123,704,000        
Balance as of beginning of period (in shares) at Dec. 31, 2020 117,734,383        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares) 126,802        
Issuance of redeemable convertible preferred stock and common stock, net of issuance costs $ 899,000        
Exchange of convertible notes and accrued interest for Series D redeemable convertible preferred stock (in shares) 6,820,022        
Conversion of convertible notes into preferred stock $ 55,577,000        
Extinguishment of redeemable convertible preferred stock (in shares) (124,681,207)        
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization $ (180,180,000)        
Balance as of end of period (in shares) at Dec. 31, 2021 0        
Balance as of beginning of period (in shares) at Dec. 31, 2020   16,003,558      
Balance as of beginning of period at Dec. 31, 2020 $ (107,821,000) $ 1,000 $ 14,954,000 $ 0 $ (122,776,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of preferred stock into common stock $ 180,180,000        
Issuance of common stock upon exercise of stock options (in shares) 269,000 269,112      
Issuance of common stock upon exercise of stock options $ 385,000   385,000    
Issuance of common stock warrants 316,000   316,000    
Extinguishment of redeemable convertible preferred stock (in shares)   126,310,700      
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization     180,180,000    
Conversion of warrants into common stock, net settlement (in shares)   239,992      
Conversion of warrants into common stock, net settlement 3,635,000   3,635,000    
Issuance of contingent earnout liability upon the reverse recapitalization 120,763,000   120,763,000    
Issuance of warrants upon the reverse recapitalization 21,051,000   21,051,000    
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)   40,409,132      
Issuance of common stock upon the reverse recapitalization, net of issuance costs 278,271,000 $ 1,000 278,270,000    
Stock-based compensation 4,368,000   4,368,000    
Net income (loss) (107,091,000)       (107,091,000)
Other comprehensive loss (14,000)     (14,000)  
Balance as of end of period (in shares) at Dec. 31, 2021   183,232,494      
Balance as of end of period at Dec. 31, 2021 110,415,000 $ 2,000 340,294,000 (14,000) (229,867,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Balance as of the end of period $ 0        
Balance as of end of period (in shares) at Dec. 31, 2022 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 2,981,000 2,980,626      
Issuance of common stock upon exercise of stock options     1,256,000    
Issuance of common stock warrants $ 170,000   170,000    
Stock-based compensation 20,148,000 $ 1,348,248 20,148,000    
Net income (loss) 10,020,000       10,020,000
Other comprehensive loss (823,000)     (823,000)  
Balance as of end of period (in shares) at Dec. 31, 2022   187,561,368      
Balance as of end of period at Dec. 31, 2022 140,846,000 $ 2,000 $ 361,528,000 $ (837,000) $ (219,847,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture 1,256,000        
Balance as of the end of period $ 0